Mathieu Bléry
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 31
- Immune Cell Function and Interaction 25
- T-cell and B-cell Immunology 4
-
- NF-κB Signaling Pathways 2
- Co-authors
- Éric Vivier (18 shared papers)Lucia Olcese (6 shared papers)Frédéric Vely (6 shared papers)Pascale André (7 shared papers)François Romagné (7 shared papers)Alessandro Moretta (3 shared papers)Anna Cambiaggi (3 shared papers)Nicolas Fuséri (5 shared papers)
- Journals
- Blood (5 papers)The Journal of Immunology (4 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (2 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Mathieu Bléry
35 papers receiving 4.1k citations
Mathieu Bléry's Hit Papers
Peers
Comparison fields: 5 of 79
- Immunology 2.8k
- Oncology 680
- Cancer Research 176
- Hematology 119
- Dermatology 70
Countries citing papers authored by Mathieu Bléry
This map shows the geographic impact of Mathieu Bléry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bléry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bléry more than expected).
Fields of papers citing papers by Mathieu Bléry
This network shows the impact of papers produced by Mathieu Bléry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bléry. The network helps show where Mathieu Bléry may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Bléry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells Hit paper breakdown → | 2018 | 996 |
| 2 | 2007 | 384 | |
| 3 | 1996 | 322 | |
| 4 | 2003 | 266 | |
| 5 | 2013 | 244 | |
| 6 | 2019 | 229 | |
| 7 | 2011 | 183 | |
| 8 | 1998 | 182 | |
| 9 | 1998 | 135 | |
| 10 | 2015 | 134 | |
| 11 | 2000 | 108 | |
| 12 | 1997 | 101 | |
| 13 | 2000 | 95 | |
| 14 | 2013 | 95 | |
| 15 | 1997 | 92 | |
| 16 | 2010 | 87 | |
| 17 | 2011 | 78 | |
| 18 | 2017 | 68 | |
| 19 | 2001 | 66 | |
| 20 | 2014 | 64 |
About Mathieu Bléry
Mathieu Bléry is a scholar working on Immunology, Cancer Research, Pathology and Forensic Medicine, Physiology and Oncology, having authored 35 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), NF-κB Signaling Pathways (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Lipid Membrane Structure and Behavior (1 paper), Protein Tyrosine Phosphatases (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Immunology (2.8k citations), Oncology (680 citations), Cancer Research (176 citations), Hematology (119 citations) and Dermatology (70 citations). Mathieu Bléry has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Éric Vivier, Lucia Olcese, Frédéric Vely, Pascale André, François Romagné, Alessandro Moretta, Anna Cambiaggi, Nicolas Fuséri, Elena Tomasello and Lisa A. Miosge. Their work appears in journals such as Blood, The Journal of Immunology, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.